| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/29/2006 | US7098382 Promoter having specific activity to pistil tissue and use of the same |
| 08/29/2006 | US7098378 altering the expressing nucleic acid molecules encoding RAR1 proteins in transgenic plants, progeny and seeds to alter the level disease resistance |
| 08/29/2006 | US7098377 transgenic mouse whose germ cells contain nucleic acid construct that disrupts the endogenous IEX-1 sequence resulting in high blood pressure; lacks expression of IEX-1 polypeptide |
| 08/29/2006 | US7098376 Expression vector coding constitutively active hydrocarbon receptor (CA-AhR) for generating animal models which screen and identify antitumor/anticarcinogenic agents |
| 08/29/2006 | US7098375 Animal and cell models for type II diabetes and their use |
| 08/29/2006 | US7098323 Polynucleotide squences and amino acid sequences for diagnosis of diseases and growth factors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098321 Homologous peptide nucleic acids |
| 08/29/2006 | US7098318 A carboxy terminal peptide fragment of thrombopoietin is fused with the carboxy terminal of human erythropoietin; highly enhanced in vivo half-life due to increased carbohydrate content; no antigenicity |
| 08/29/2006 | US7098316 Isolated nucleic acid, coding regions of genes of proteins, vectors, host cells and genetic engineering for producing proteins and diagnosis of diseaes |
| 08/29/2006 | US7098315 Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 08/29/2006 | US7098314 Controller for reproduction in the pituitary of Epinephelus, DNA sequences and use, expression vectors with sequences to control reproduction |
| 08/29/2006 | US7098313 DNA sequences coding for a polyol carrier and their use, in particular for the preparation of transgenic plants |
| 08/29/2006 | US7098312 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2006 | US7098311 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cell proliferative disorders |
| 08/29/2006 | US7098310 Screening ligands for their effect on the activity of an RXR-containing hormone receptor heterodimer comprising combining the heterodimer with the ligand and determining the effect on activity |
| 08/29/2006 | US7098309 Recombinant hepatitis B surface antigen |
| 08/29/2006 | US7098307 Neo-tryptophan |
| 08/29/2006 | US7098306 Method and compositions for treating hepatocellular cancer |
| 08/29/2006 | US7098304 Peptides that bind antibodies that are found in elevated levels in body fluids of schizophrenic patients and are found at a lower level or not found at all in body fluids of non-schizophrenic individuals |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098302 Epidermal growth factor receptor; prevention and treatment of disorders associated with overexpression of ErbB2 (e.g., breast cancer). |
| 08/29/2006 | US7098187 for inhibiting endothelial cell proliferation or endothelial tube formation in in vitro or in vivo bioassay |
| 08/29/2006 | US7098185 Comprises matrix extracellular phosphoglycoprotein (MEPE) for diagnosing and treating rickets, urogenital, kidney and bone disorders |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7098183 cell growth differentiation factors/polypeptides for immunization; animal models |
| 08/29/2006 | US7098182 Grampositive bacterial polypeptides for vaccine development and screening microorganismal genomes to isolate and characterize bacterial cell envelope associated or secreted polypeptides; microbiocides; infection prevention |
| 08/29/2006 | US7098029 Product and method for control of obesity |
| 08/29/2006 | US7098028 Preparing in vitro cell cultures utilizing self assembling macroscopic membranes for use as slow-diffusion drug delivery systems, artificial skin, separation matrices and animal model for alzheimer's and viral diseases |
| 08/29/2006 | US7098026 Human desert hedgehog protein |
| 08/29/2006 | US7098025 Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses therefor |
| 08/29/2006 | US7098005 Preparing methylomonas regulatory sequence for use in the expression of heterologous sequences and protein in methanotrophs and methylotrophs; carotenoid biosynthesis |
| 08/29/2006 | US7098004 Isolated polypeptide of the stratum corneum and its use |
| 08/29/2006 | US7098002 Preparation of biologically active molecules |
| 08/29/2006 | US7097999 Method for producing target substance using microorganisms with reduced interactions between MalK and IIAGlc |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | US7097990 Method of screening cell death inhibitor |
| 08/29/2006 | US7097987 Hepatitis C receptor protein CD81 |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097982 Peptides and compositions which modulate apoptosis |
| 08/29/2006 | US7097978 Screening methods based on isolating a collection of polynucleotides corresponding to accessible regions of chromatin |
| 08/29/2006 | US7097977 Target of anticancer agent |
| 08/29/2006 | US7097972 invention provides non-naturally occurring and isolated naturally occurring nucleic acid molecules which code proteins designated Yama Pro-Yama and non-naturally occurring nucleic acid molecule coding mutant CrmA protein and dominant inhibitory Yama.Vectors and host cells containing these nucleic acids |
| 08/29/2006 | US7097971 novel peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 08/29/2006 | US7097969 IDENTIFYING AN ALLOSTERIC MODULATOR/ANTAGONIST OF G-PROTEIN COUPLED RECEPTORS FOR TREATMENT OF METABOLIC DISORDERS and diseases that have been linked to overactive GPCRs, because traditional neutral-antagonists will not block abnormal ligand-independent activity of these receptors |
| 08/29/2006 | US7097966 Medical diagnosis of bladder cancer |
| 08/29/2006 | US7097965 Targeting antigens to the MHC class I processing pathway with an anthrax toxin fusion protein |
| 08/29/2006 | US7097846 35 kD tumor associated protein antigen: uses and methods of detection |
| 08/29/2006 | US7097844 T helper cell epitopes |
| 08/29/2006 | US7097843 Immunogenic peptides from the HPV E7 protein |
| 08/29/2006 | US7097841 Ferritin fusion proteins for use in vaccines and other applications |
| 08/29/2006 | US7097839 A conjugated compound contains antibody or a Fab, and a radiostable therapeutic active agent; for diagnosis/therapy of colorectal cancer; biological conjugated drugs |
| 08/29/2006 | US7097834 Osteoprotegerin binding proteins |
| 08/29/2006 | US7097829 Transgenic cells transfected with pituitary tumor transforming gene (PTTG)) expression vectors and uses therefor |
| 08/29/2006 | CA2318851C Recombinant human mannan-binding proteins and process for producing the same |
| 08/29/2006 | CA2187974C Newcastle disease virus combination vaccine |
| 08/29/2006 | CA2111238C Production of a protein of interest in the milk of a transgenic mammal |
| 08/24/2006 | WO2006089251A2 SYNERGISTIC EFFECT OF TGF-β BLOCKADE AND IMMUNOGENIC AGENTS ON TUMORS |
| 08/24/2006 | WO2006089107A1 Polypeptides having alpha-amylase and granular starch hydrolyzing activity |
| 08/24/2006 | WO2006088955A2 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells |
| 08/24/2006 | WO2006088855A1 Methods of treating skin disorders using an il-31ra antagonist |
| 08/24/2006 | WO2006088833A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor |
| 08/24/2006 | WO2006088803A2 Polypeptides from staphylococcus aureus and methods of use |
| 08/24/2006 | WO2006088508A2 Cupredoxin derived transport agents and methods of use thereof |
| 08/24/2006 | WO2006088229A1 Modified virus capsid protein and the use thereof |
| 08/24/2006 | WO2006088198A1 Method of producing protein by using hamster igf-1 |
| 08/24/2006 | WO2006088110A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein |
| 08/24/2006 | WO2006087624A1 Pharmaceutical composition and relative use for the treatment and prevention of prostate tumour |
| 08/24/2006 | WO2006087550A2 Amyloid-binding peptides, analogues and uses thereof |
| 08/24/2006 | WO2006087539A1 Peptides, nucleic acids and materials |
| 08/24/2006 | WO2006087340A2 Highly potent full and partial agonists and antagonists of the nociceptin/orphanin fq receptor |
| 08/24/2006 | WO2006086870A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | WO2006086823A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | WO2006086822A1 A molecule and chimeric molecules thereof |
| 08/24/2006 | WO2006066925A3 Novel genes involved in gluconeogenesis |
| 08/24/2006 | WO2006060699A9 Methods of increasing seed yield |
| 08/24/2006 | WO2006058226A3 Modified dimeric streptavidins and uses thereof |
| 08/24/2006 | WO2006056987A3 Leptin antagonists |
| 08/24/2006 | WO2006051418A3 Transcription factor of the zn binuclear cluster family of fungal regulators |
| 08/24/2006 | WO2006050394A3 Combination approaches for generating immune responses |
| 08/24/2006 | WO2006046239B1 A thymus-specific protein |
| 08/24/2006 | WO2006045103A3 Device and method for removing heavy metals from contaminated samples with membranes comprising purified metallothionein |
| 08/24/2006 | WO2006043079A3 Compositions and methods for the control of mammary cell number |
| 08/24/2006 | WO2006042027A3 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 08/24/2006 | WO2006041945A3 A counterion exchange process for peptides |
| 08/24/2006 | WO2006038131A3 Inhibitors of infection |
| 08/24/2006 | WO2006031213A8 Single -pass image warping system and mehtod with anisotropic filtering |
| 08/24/2006 | WO2006024954A3 Domains and epitopes of meningococcal protein nmb1870 |
| 08/24/2006 | WO2006016808A3 Means and methods for producing a stabilized cell of interest |
| 08/24/2006 | WO2006013388A3 Materials and methods for modulating signalling by alpha-v integrin molecules |
| 08/24/2006 | WO2006010558A8 Tumor-homing cells engineered to produce tumor necrosis factor-related apoptosis-inducing ligand (trail) |
| 08/24/2006 | WO2006000213A3 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 08/24/2006 | WO2005081945A3 Diagnosis or treatment of endothelial cell dysfunction related diseases |
| 08/24/2006 | WO2005051973A3 Peptides derived from natural cytotoxicity receptors and methods of use thereof |
| 08/24/2006 | WO2005027725A3 Determination of ions using ion-sensitive enzymes |
| 08/24/2006 | WO2005001036A8 Novel trichoderma genes |
| 08/24/2006 | WO2004043397A3 Compositions and methods for the treatment of rheumatoid arthritis |
| 08/24/2006 | WO2004016734A3 Nucleic acids and corresponding proteins entitled 282p1g3 useful in treatment and detection of cancer |
| 08/24/2006 | WO2003087300A3 Secreted proteins |
| 08/24/2006 | US20060191042 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |